Australia Markets open in 9 hrs 18 mins

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.19-0.67 (-3.55%)
As of 10:42AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close18.86
Bid18.04 x 2200
Ask18.03 x 1300
Day's range17.91 - 18.66
52-week range12.52 - 36.55
Avg. volume688,274
Market cap840.636M
Beta (5Y monthly)0.88
PE ratio (TTM)N/A
EPS (TTM)-2.81
Earnings date24 Oct 2022 - 28 Oct 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est52.19
  • GlobeNewswire

    uniQure to Participate in Upcoming Industry Conferences in September

    LEXINGTON, Mass. and AMSTERDAM, Sept. 06, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences: Citi’s 17th Annual BioPharma Conference, September 7 – 8, 2022 Members of uniQure’s management team, including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research

  • Simply Wall St.

    These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts

    The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...

  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.